Payment overview · 2025
General Payments
$88.00
4 reported records · 4 companies
Healthcare provider profile · identity verified
Thomas Warren Hobby, DO
Allopathic & Osteopathic Physicians|Internal Medicine · VALDOSTA, GA · NPI 1497749733
Verified facts
What the public records show
CMS Open Payments records show Thomas Warren Hobby, DO received $88.00 in general payments during 2025 across 4 reported records.
Boston Scientific Corporation accounted for 31.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
Astellas Pharma US Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Myrbetriq as an associated drug or biological on 16 records involving 16 distinct recipient NPIs. Public Medicare Part D data also shows 52 claims for Myrbetriq by this doctor in 2024.
SANOFI-AVENTIS U.S. LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LANTUS as an associated drug or biological on 12 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Lantus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $27.98 | 31.8% | 1 | 2025 |
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $23.08 | 26.2% | 1 | 2025 |
| Seqirus USA Inc | Unresolved — no canonical attribution shown | $18.84 | 21.4% | 1 | 2025 |
| SANOFI-AVENTIS U.S. LLC | Unresolved — no canonical attribution shown | $18.10 | 20.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $88.00 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| WATCHMAN Access System Normalized: watchman access system |
Device | Boston Scientific Corporation | $27.98 | 1 | 2025 |
Source payment records
|
|||||
| Veozah Normalized: veozah |
Drug | Astellas Pharma US Inc | $23.08 | 1 | 2025 |
Source payment records
|
|||||
| Fluad Normalized: fluad |
Biological | Seqirus USA Inc | $18.84 | 1 | 2025 |
Source payment records
|
|||||
| Flucelvax Normalized: flucelvax |
Biological | Seqirus USA Inc | $18.84 | 1 | 2025 |
Source payment records
|
|||||
| TZIELD Normalized: tzield |
Biological | SANOFI-AVENTIS U.S. LLC | $18.10 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Astellas Pharma US Inc Exact reporting entity; no affiliate inference |
2025 | Myrbetriq open payments reported associated product |
CMS Open Payments — General Payments 16 supporting records · 16 recipient NPIs · example record 1238599014 |
Myrbetriq · 2024 Exact normalized brand match · 1 Part D row |
52 | suppressed by CMS |
| SANOFI-AVENTIS U.S. LLC Exact reporting entity; no affiliate inference |
2025 | LANTUS open payments reported associated product |
CMS Open Payments — General Payments 12 supporting records · 11 recipient NPIs · example record 1233196856 |
Lantus · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 642 | 146 |
| Losartan Potassium | Losartan Potassium | 480 | 122 |
| Amlodipine Besylate | Amlodipine Besylate | 427 | 105 |
| Levothyroxine Sodium | Levothyroxine Sodium | 398 | 84 |
| Omeprazole | Omeprazole | 388 | 88 |
| Potassium Chloride | Potassium Chloride | 372 | 70 |
| Simvastatin | Simvastatin | 321 | 81 |
| Metformin Hcl | Metformin Hcl | 296 | 75 |
| Metoprolol Succinate | Metoprolol Succinate | 268 | 58 |
| Alprazolam | Alprazolam | 266 | 41 |
| Pantoprazole Sodium | Pantoprazole Sodium | 263 | 59 |
| Metoprolol Tartrate | Metoprolol Tartrate | 248 | 60 |
| Furosemide | Furosemide | 243 | 58 |
| Lisinopril | Lisinopril | 218 | 47 |
| Citalopram Hbr | Citalopram Hydrobromide | 213 | 40 |
| Gabapentin | Gabapentin | 209 | 59 |
| Hydrochlorothiazide | Hydrochlorothiazide | 193 | 55 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 191 | 41 |
| Temazepam | Temazepam | 188 | 35 |
| Tramadol Hcl | Tramadol Hcl | 169 | 37 |
| Azithromycin | Azithromycin | 167 | 132 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 163 | 41 |
| Meloxicam | Meloxicam | 161 | 42 |
| Montelukast Sodium | Montelukast Sodium | 161 | 38 |
| Eliquis | Apixaban | 158 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 157 | 33 |
| Methylprednisolone | Methylprednisolone | 157 | 134 |
| Allopurinol | Allopurinol | 153 | 35 |
| Zolpidem Tartrate | Zolpidem Tartrate | 148 | 20 |
| Tamsulosin Hcl | Tamsulosin Hcl | 129 | 31 |
| Ezetimibe | Ezetimibe | 117 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 111 | 26 |
| Sertraline Hcl | Sertraline Hcl | 106 | 24 |
| Atenolol | Atenolol | 90 | 20 |
| Celecoxib | Celecoxib | 87 | 18 |
| Fenofibrate | Fenofibrate | 86 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 86 | 20 |
| Clonazepam | Clonazepam | 84 | 12 |
| Januvia | Sitagliptin Phosphate | 82 | 18 |
| Pravastatin Sodium | Pravastatin Sodium | 82 | 24 |
| Lorazepam | Lorazepam | 81 | 13 |
| Donepezil Hcl | Donepezil Hcl | 78 | 16 |
| Famotidine | Famotidine | 71 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 69 | 16 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 69 | 53 |
| Trazodone Hcl | Trazodone Hcl | 67 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 66 | 12 |
| Warfarin Sodium | Warfarin Sodium | 66 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 64 | 17 |
| Xarelto | Rivaroxaban | 64 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 63 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 63 | 18 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 60 | 51 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 60 | 15 |
| Fenofibrate | Fenofibrate Nanocrystallized | 60 | 11 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 57 | 21 |
| Synthroid | Levothyroxine Sodium | 53 | 11 |
| Glimepiride | Glimepiride | 52 | 16 |
| Myrbetriq | Mirabegron | 52 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 51 | 18 |
| Finasteride | Finasteride | 51 | suppressed |
| Carvedilol | Carvedilol | 50 | 15 |
| Ramipril | Ramipril | 50 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 49 | 13 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 46 | 19 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 46 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 44 | suppressed |
| Spironolactone | Spironolactone | 44 | suppressed |
| Eszopiclone | Eszopiclone | 42 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 39 | suppressed |
| Pregabalin | Pregabalin | 38 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 37 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 37 | suppressed |
| Diazepam | Diazepam | 36 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 35 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 34 | 30 |
| Valacyclovir | Valacyclovir Hcl | 34 | 16 |
| Farxiga | Dapagliflozin Propanediol | 33 | suppressed |
| Ozempic | Semaglutide | 33 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 32 | 17 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 32 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 31 | 12 |
| Trulicity | Dulaglutide | 31 | suppressed |
| Baclofen | Baclofen | 30 | suppressed |
| Levetiracetam | Levetiracetam | 30 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 29 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 28 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 28 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 28 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 28 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 26 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 26 | suppressed |
| Dutasteride | Dutasteride | 25 | suppressed |
| Jardiance | Empagliflozin | 25 | suppressed |
| Nifedipine Er | Nifedipine | 25 | suppressed |
| Torsemide | Torsemide | 25 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 25 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 24 | suppressed |
| Felodipine Er | Felodipine | 23 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 23 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 22 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 22 | suppressed |
| Gemfibrozil | Gemfibrozil | 22 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 22 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 22 | suppressed |
| Prednisone | Prednisone | 22 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 21 | suppressed |
| Tradjenta | Linagliptin | 21 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 19 | suppressed |
| Bumetanide | Bumetanide | 19 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 19 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 19 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 18 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 18 | 14 |
| Diltiazem 24hr Er | Diltiazem Hcl | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Jantoven | Warfarin Sodium | 18 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 18 | suppressed |
| Valsartan | Valsartan | 18 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 17 | suppressed |
| Calcitriol | Calcitriol | 17 | suppressed |
| Sotalol | Sotalol Hcl | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 15 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 15 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Bupropion Xl | Bupropion Hcl | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 14 | suppressed |
| Olanzapine | Olanzapine | 14 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 14 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 14 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Memantine Hcl | Memantine Hcl | 13 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | 11 |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Trimethoprim | Trimethoprim | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Alogliptin-Pioglitazone | Alogliptin Benz/Pioglitazone | 12 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | suppressed |
| Xyosted | Testosterone Enanthate | 12 | suppressed |
| Acarbose | Acarbose | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 11 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 11 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 11 | 11 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Paroxetine Cr | Paroxetine Hcl | 11 | suppressed |
| Victoza 2-Pak | Liraglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $88.00 · 4 records | Boston Scientific Corporation | Fluad, Flucelvax, TZIELD, Veozah, WATCHMAN Access System | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Astellas Pharma US Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error